| Keyword search (4,164 papers available) | ![]() |
"Dagher A" Authored Publications:
| Title | Authors | PubMed ID | |
|---|---|---|---|
| 1 | Mapping cerebral blood perfusion and its links to multi-scale brain organization across the human lifespan | Farahani A; Liu ZQ; Ceballos EG; Hansen JY; Wennberg K; Zeighami Y; Dadar M; Gauthier CJ; Dagher A; Misic B; | 40729400 PHYSICS |
| 2 | A multimodal neuroimaging study of youth at risk for substance use disorders: Functional magnetic resonance imaging and [18F]fallypride positron emission tomography | Nikolic M; Cox SML; Jaworska N; Castellanos-Ryan N; Dagher A; Vitaro F; Brendgen M; Parent S; Boivin M; Côté S; Tremblay RE; Séguin JR; Leyton M; | 39725679 CSBN |
| 3 | A dataset of multi-contrast unbiased average MRI templates of a Parkinson's disease population | Madge V; Fonov VS; Xiao Y; Zou L; Jackson C; Postuma RB; Dagher A; Fon EA; Collins DL; | 37213552 IMAGING |
| 4 | Correspondence between gene expression and neurotransmitter receptor and transporter density in the human brain | Hansen JY; Markello RD; Tuominen L; Nørgaard M; Kuzmin E; Palomero-Gallagher N; Dagher A; Misic B; | 36209794 CSBN |
| 5 | Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: An exploratory PET imaging study with [(18)F]-FEOBV | Legault-Denis C; Aghourian M; Soucy JP; Rosa-Neto P; Dagher A; Aumont E; Wickens R; Bedard MA; | 34628195 PERFORM |
| 6 | Cocaine cue-induced mesocorticolimbic activation in cocaine users: Effects of personality traits, lifetime drug use, and acute stimulant ingestion | D' Amour-Horvat V; Cox SML; Dagher A; Kolivakis T; Jaworska N; Leyton M; | 34463411 CSBN |
| 7 | mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use. | Cox SML, Tippler M, Jaworska N, Smart K, Castellanos-Ryan N, Durand F, Allard D, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté S, Tremblay RE, Séguin JR, Leyton M | 32413893 CSBN |
| 8 | Extra-striatal D2/3 receptor availability in youth at risk for addiction. | Jaworska N, Cox SML, Tippler M, Castellanos-Ryan N, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté SM, Tremblay RE, Séguin JR, Leyton M | 32259831 CSBN |
| 9 | Cocaine cue-induced dopamine release in the human prefrontal cortex. | Milella MS, Fotros A, Gravel P, Casey KF, Larcher K, Verhaeghe JA, Cox SM, Reader AJ, Dagher A, Benkelfat C, Leyton M | 26900792 CSBN |
| 10 | Cyberinfrastructure for Open Science at the Montreal Neurological Institute. | Das S, Glatard T, Rogers C, Saigle J, Paiva S, MacIntyre L, Safi-Harab M, Rousseau ME, Stirling J, Khalili-Mahani N, MacFarlane D, Kostopoulos P, Rioux P, Madjar C, Lecours-Boucher X, Vanamala S, Adalat R, Mohaddes Z, Fonov VS, Milot S, Leppert I, Degroot C, Durcan TM, Campbell T, Moreau J, Dagher A, Collins DL, Karamchandani J, Bar-Or A, Fon EA, Hoge R, Baillet S, Rouleau G, Evans AC | 28111547 IMAGING |
| 11 | Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers. | Booij L, Welfeld K, Leyton M, Dagher A, Boileau I, Sibon I, Baker GB, Diksic M, Soucy JP, Pruessner JC, Cawley-Fiset E, Casey KF, Benkelfat C | 26905412 PSYCHOLOGY |
| Title: | mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use. | ||||
| Authors: | Cox SML, Tippler M, Jaworska N, Smart K, Castellanos-Ryan N, Durand F, Allard D, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté S, Tremblay RE, Séguin JR, Leyton M | ||||
| Link: | https://www.ncbi.nlm.nih.gov/pubmed/32413893?dopt=Abstract | ||||
| DOI: | 10.1038/s41386-020-0708-x | ||||
| Publication: | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology | ||||
| Keywords: | |||||
| PMID: | 32413893 | Category: | Neuropsychopharmacology | Date Added: | 2020-05-16 |
| Dept Affiliation: |
CSBN
1 Department of Psychiatry, McGill University, Montreal, QC, Canada. 2 Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. 3 Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada. 4 Institute of Mental Health Research, Affiliated with the University of Ottawa, Ottawa, ON, Canada. 5 Yale PET Center, Yale University, New Haven, CT, USA. 6 School of Psychoeducation, Université de Montréal, Montreal, QC, Canada. 7 CHU Ste-Justine Research Center, Montreal, QC, Canada. 8 Department of Psychology, Université Laval, Quebec, QC, Canada. 9 Department of Psychology, McGill University, Montreal, QC, Canada. 10 Department of Social and Preventative Medicine, Université de Montréal, Montreal, QC, Canada. 11 Department of Pediatrics and Psychology, Université de Montréal, Montreal, QC, Canada. 12 School of Public Health, University College Dublin, Belfield, Dublin, Ireland. 13 Department of Psychiatry and Addictology, Université de Montréal, Montreal, QC, Canada. 14 Department of Psychiatry, McGill University, Montreal, QC, Canada. marco.leyton@mcgill.ca. 15 Department of Neurology & Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, QC, Canada. marco.leyton@mcgill.ca. 16 Department of Psychology, McGill University, Montreal, QC, Canada. marco.leyton@mcgill.ca. 17 Center for Studies in Behavioral Neurobiology, Concordia University, Montreal, QC, Canada. marco.leyton@mcgill.ca. |
||||
Description: |
mGlu5 receptor availability in youth at risk for addictions: effects of vulnerability traits and cannabis use. Neuropsychopharmacology. 2020 May 15;: Authors: Cox SML, Tippler M, Jaworska N, Smart K, Castellanos-Ryan N, Durand F, Allard D, Benkelfat C, Parent S, Dagher A, Vitaro F, Boivin M, Pihl RO, Côté S, Tremblay RE, Séguin JR, Leyton M Abstract PMID: 32413893 [PubMed - as supplied by publisher] |



